Jane Street’s Franklin Genomic Advancements ETF HELX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-8,049
| Closed | -$217K | – | 5899 |
|
|
2025
Q1 | $217K | Sell |
8,049
-32,981
| -80% | -$891K | ﹤0.01% | 4909 |
|
|
2024
Q4 | $1.18M | Buy |
+41,030
| New | +$1.18M | ﹤0.01% | 2726 |
|
|
2024
Q2 | – | Sell |
-13,886
| Closed | -$455K | – | 6271 |
|
|
2024
Q1 | $455K | Sell |
13,886
-11,923
| -46% | -$391K | ﹤0.01% | 4164 |
|
|
2023
Q4 | $786K | Buy |
25,809
+12,821
| +99% | +$391K | ﹤0.01% | 3612 |
|
|
2023
Q3 | $368K | Buy |
12,988
+274
| +2% | +$7.76K | ﹤0.01% | 3873 |
|
|
2023
Q2 | $384K | Buy |
12,714
+3,158
| +33% | +$95.5K | ﹤0.01% | 4006 |
|
|
2023
Q1 | $290K | Sell |
9,556
-4,924
| -34% | -$150K | ﹤0.01% | 4284 |
|
|
2022
Q4 | $436K | Sell |
14,480
-17
| -0.1% | -$512 | ﹤0.01% | 3554 |
|
|
2022
Q3 | $430K | Buy |
14,497
+141
| +1% | +$4.18K | ﹤0.01% | 3773 |
|
|
2022
Q2 | $460K | Buy |
14,356
+7,462
| +108% | +$239K | ﹤0.01% | 3658 |
|
|
2022
Q1 | $255K | Sell |
6,894
-107,429
| -94% | -$3.97M | ﹤0.01% | 4463 |
|
|
2021
Q4 | $5.55M | Buy |
+114,323
| New | +$5.55M | ﹤0.01% | 1007 |
|
|
2021
Q3 | – | Sell |
-36,210
| Closed | -$1.88M | – | 5473 |
|
|
2021
Q2 | $1.88M | Sell |
36,210
-5,568
| -13% | -$288K | ﹤0.01% | 1826 |
|
|
2021
Q1 | $1.81M | Buy |
41,778
+15,833
| +61% | +$686K | ﹤0.01% | 1754 |
|
|
2020
Q4 | $1.15M | Buy |
25,945
+18,426
| +245% | +$816K | ﹤0.01% | 1962 |
|
|
2020
Q3 | $264K | Buy |
+7,519
| New | +$264K | ﹤0.01% | 2985 |
|